https://www.selleckchem.com/pr....oducts/sodium-ascorb
The overall pelvic control was 89%. The overall recurrence rate was 25% and distant metastases rate was 22%. The overall 5-year survival rate was 65% and cancer-specific survival rate was 69%. Prognostic factors were FIGO stage and total brachytherapy dose (D ) to HRCTV. Late serious toxicity of the bladder and intestine were rare, occurring in only 3% of patients. The local and pelvic control rates were excellent in this series. The IGABT was an important part of the treatment schedule and could probably not be replaced by inc
Like
Comment
Share
